儿童肾母细胞瘤临床病理资料与预后的影响因素分析

Clinicopathological data and prognostic factors of nephroblastoma in children

目的:探讨儿童肾母细胞瘤临床病理因素与预后的相关性。方法:回顾性分析2008年1月—2020年12月安徽省儿童医院收治的75例肾母细胞瘤患者的临床病理资料,分析患者的年龄、性别、发病部位、临床分期、病理类型、Ki-67增殖指数、治疗方法与预后的相关性。采用SPSS 26.0对数据进行统计分析,Graphpad prism7绘图,Kaplan-Meier生存分析中的log-rank检验对不同组间累积无进展生存率进行比较,Cox比例风险模型筛选出影响患者预后的相关因素。结果:75例患者,男44例、女31例,平均年龄(2.40±2.01)岁。中位随访时间84个月,期间15例死亡。log-rank检验结果显示,年龄、临床分期、病理类型和Ki-67增殖指数与预后有一定的相关性,多变量分析显示,年龄、临床分期和病理类型为影响患者疾病进展或死亡的危险因素。结论:肾母细胞瘤是儿童最常见的泌尿系统肿瘤,早期发现、正确诊断、明确分期能协助临床医生评估个体风险,选择最佳治疗方法,提高生存率,改善预后。

Objective To investigate the correlations between the clinicopathological factors and prognosis of nephroblastoma in children.Methods The clinicopathological data of 75 children with nephroblastoma treated in Anhui Children's Hospital from January 2008 to December 2020 were analyzed retrospectively.The correlations of prognosis with age,gender,location of onset,clinical stage,pathological type,Ki-67 proliferation index and treatment method were analyzed.The data were statistically analyzed using SPSS 26.0,and relevant charts were drawn with Graphpad Prism 7.In Kaplan-Meier survival analysis,the cumulative progression-free survival rates among various groups were compared using the log-rank test.The relevant factors influencing the prognoses in children were screened using the Cox proportional hazards model.Results A total of 75 children were enrolled,including 44 boys and 31 girls,with an average age of(2.40±2.01)years.During the median follow-up duration of 84 months,15 children died.On the one hand,the log-rank test showed that age,clinical stage,pathological type and Ki-67 proliferation index were correlated with the prognosis.On the other hand,multivariate analysis demonstrated that age,clinical stage and pathological type were the risk factors influencing disease progression or death.Conclusion Nephroblastoma is the most common tumor of the urinary system in children.Early detection,correct diagnosis and definite staging can help clinicians evaluate individual risk,select the optimal treatment,enhance survival rate and improve prognosis.